U.S. Interactive Media and Services Stock News

NasdaqGS:OKTA
NasdaqGS:OKTAIT

Okta Extends Identity Reach To AI Agents And Resilience With Commvault

Okta (NasdaqGS:OKTA) is expanding its identity security platform to cover AI agents and new AI focused identity products. The company announced a new product partnership with Commvault to support identity resilience and recovery for Okta environments. Okta sits at the center of how companies manage digital identities, which is becoming more complex as AI agents start to interact with systems and data on behalf of users. Linking identity security to AI is a logical extension of Okta’s core...
NasdaqGS:MGNI
NasdaqGS:MGNIMedia

Is Real-Time Sports Data In ClearLine Altering The Investment Case For Magnite (MGNI)?

In February and March 2026, Genius Sports announced a direct integration of its official Moment Engine with Magnite's ClearLine platform, embedding verified, real-time sports signals into Magnite's sell-side infrastructure to let advertisers activate campaigns around authenticated in-game moments across premium CTV and digital inventory. This collaboration, alongside Magnite's recently reported 2025 earnings growth, new US$200 million share repurchase authorization, and ongoing buybacks,...
NasdaqGM:QCRH
NasdaqGM:QCRHBanks

A Look At QCR Holdings (QCRH) Valuation After Recent Share Price Pullback

QCR Holdings overview QCR Holdings (QCRH) has drawn attention after recent trading left the shares showing mixed return patterns, with a monthly pullback alongside a positive year and multi year total return profile for investors watching regional banks. See our latest analysis for QCR Holdings. At a share price of US$83.05, QCR Holdings has recently seen a 10.26% 1 month share price decline and softer short term momentum, even though its 1 year and 3 year total shareholder returns of 16.03%...
NasdaqGS:PRVA
NasdaqGS:PRVAHealthcare

A Look At Privia Health Group (PRVA) Valuation After Strong Earnings And Colorectal Screening Progress

Privia Health Group (PRVA) has drawn fresh investor interest after reporting quarterly and full year 2025 results, issuing 2026 revenue guidance, and highlighting a nationwide colorectal cancer screening program built around its technology platform. See our latest analysis for Privia Health Group. At a share price of US$23.27, Privia Health Group has seen a 5.72% 1 month share price return, while its 1 year total shareholder return of an 8.89% decline suggests longer term momentum has been...
NYSE:RERE
NYSE:RERESpecialty Retail

Is It Time To Reassess ATRenew (RERE) After Strong Three Year Share Price Gains

If you are trying to work out whether ATRenew is attractively priced or starting to look stretched, its recent share price and fundamentals give you plenty to weigh up. The stock closed at US$5.26, with returns of a 9.2% decline over the last 7 days and a 4.9% decline over 30 days, but it is still up 3.0% year to date and 56.1% over the past year, plus 82.0% over three years. These moves have played out against a backdrop of ongoing interest in the recommerce and electronics resale space, as...
NYSE:TE
NYSE:TEElectrical

T1 Energy (TE) Valuation Check After Encompass Capital Boosts Stake To Top Holding

Encompass Capital Advisors’ recent purchase of an additional 21.5 million T1 Energy (TE) shares, making the stock one of its top holdings, has placed this lithium ion battery producer squarely on investors’ radar. See our latest analysis for T1 Energy. The share price has been volatile around recent headlines, with a 9.09% 7 day share price return and 15.27% 90 day share price return set against a 14.29% decline year to date. The 1 year total shareholder return of 380% contrasts with weaker 3...
NYSE:T
NYSE:TTelecom

How Investors May Respond To AT&T (T) Pairing Long-Dated Eurobonds With AI-Driven 5G Network Investments

In early March 2026, AT&T Inc. issued new fixed-rate, callable Eurobond notes in Canada, raising about C$2.24 billion across 4.5% 2036 and 5.25% 2056 unsecured issues. These long-dated bonds, combined with AT&T’s recent 5G/Cloud RAN and fiber initiatives, highlight how the company is pairing network innovation with active balance sheet management. Now we’ll examine how this fresh long-term funding, alongside AT&T’s AI-enabled 5G/Cloud RAN progress, could influence its investment narrative...
NYSE:BW
NYSE:BWElectrical

Why Babcock & Wilcox (BW) Is Up 47.9% After Securing US$2.4 Billion AI Power Deal – And What's Next

Babcock & Wilcox Enterprises recently reported full-year 2025 results, with sales of US$587.7 million and a net loss of US$36.2 million, while also turning a fourth-quarter profit of US$9.2 million. A key development was the full notice to proceed on a US$2.40 billion design-build agreement to deliver 1.2 gigawatts of natural gas-fired power for AI data center campuses, materially expanding the company’s large-project workload and reinforcing its role in powering energy-intensive computing...
NYSE:HLT
NYSE:HLTHospitality

Will AI Upgrades and Global Demand Shift Hilton Worldwide's (HLT) Investment Narrative?

In early March 2026, Hilton Worldwide highlighted strong international demand, growing group bookings, tight cost control and AI-powered technology upgrades as key drivers of its upbeat outlook for 2026. At the same time, options market bearishness and a pullback to a historically supportive trendline have drawn attention to Hilton as a potential contrarian idea, alongside a consensus “Moderate Buy” view from Wall Street analysts. We’ll now examine how management’s confidence in AI-enabled...
NasdaqGM:ALNT
NasdaqGM:ALNTElectrical

Allient (ALNT) Earnings Growth Outpaces Sales And Tests Premium 56x P/E Narrative

Allient (ALNT) just capped FY 2025 with fourth quarter revenue of US$143.4 million and basic EPS of US$0.38, alongside trailing twelve month revenue of US$554.5 million and EPS of US$1.32 that reflects a 28.7% rise in earnings over the past year. The company has seen revenue move from US$529.97 million on a trailing basis in FY 2024 to US$554.48 million in FY 2025, while trailing EPS stepped up from US$0.80 to US$1.32, setting up a story where profit growth is running ahead of sales and...
NYSE:ITW
NYSE:ITWMachinery

Is Illinois Tool Works (ITW) Pricing Look Attractive After Recent Share Price Weakness

If you are wondering whether Illinois Tool Works is priced attractively right now, it helps to start with how the market has been treating the stock recently and how that lines up with its fundamentals. The share price last closed at US$277.16, with a 7 day return of a 4.6% decline and a 30 day return of a 4.0% decline. The year to date return sits at 11.1% and the 1 year return at 3.5%, compared with 29.1% over 3 years and 44.1% over 5 years. Recent coverage around Illinois Tool Works has...
NYSE:ABBV
NYSE:ABBVBiotechs

Assessing AbbVie (ABBV) Valuation After New US$380 Million Facilities And Positive Skyrizi Crohn’s Data

AbbVie (ABBV) has just paired two meaningful updates: a US$380 million build out of new Illinois API facilities and positive Phase 3 Crohn's data for Skyrizi, giving investors fresh information on both capacity and pipeline. See our latest analysis for AbbVie. Against this backdrop of new clinical and manufacturing updates, AbbVie’s share price has had a mixed few months, with a 5.99% 30 day share price return and a much stronger 157.47% five year total shareholder return, suggesting that...
NasdaqGS:PLUS
NasdaqGS:PLUSElectronic

Is It Time To Reassess ePlus (PLUS) After The Recent Share Price Pullback

If you are wondering whether ePlus at around US$78 is still attractively priced or already baking in a lot of optimism, this breakdown is for you. The stock has pulled back recently, with a 3.3% decline over 7 days and a 9.4% decline over 30 days, even though the 1-year return sits at 20.1% and the 3-year return at 59.7%. These mixed returns over different time frames have put more attention on what is actually driving sentiment around ePlus and whether the share price is now more sensitive...
NasdaqGS:NDSN
NasdaqGS:NDSNMachinery

Assessing Nordson (NDSN) Valuation After Recent Share Price Weakness And Mixed Timeframe Returns

Recent performance snapshot and what it might mean for investors Nordson (NDSN) has attracted fresh attention after recent share price moves, with the stock showing a 2.9% decline over the past day and a 7% decline over the past week. Over the past month Nordson has recorded a 4.6% decline, while the past 3 months show a 14.2% total return and the past year a 28.6% total return. This gives investors mixed timeframes to weigh. See our latest analysis for Nordson. When you zoom out, Nordson’s...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

SoFiUSD Mastercard Deal Tests Valuation As SoFi Targets Blockchain Payments

SoFi Technologies (NasdaqGS:SOFI) has partnered with Mastercard to support SoFiUSD, its fully reserved stablecoin, as a settlement option on Mastercard’s global payment network. The integration uses SoFi’s Galileo platform and public blockchain infrastructure, with BitGo involved on the digital asset custody side. SoFiUSD is described as the first stablecoin issued by a nationally chartered, FDIC insured U.S. bank to connect with a major payments network on a public blockchain. For you as...
NYSE:PATH
NYSE:PATHSoftware

UiPath Targets Healthcare Automation With Agentic AI As Valuation Appears Discounted

UiPath (NYSE:PATH) has introduced a healthcare focused suite of agentic AI automation tools. The company has also formed a partnership with Genzeon, a firm with deep payer domain expertise. The new offerings are aimed at applying automation to complex and highly regulated healthcare operations. For investors watching UiPath, this move signals an effort to extend its automation platform into healthcare, an industry where workflows are often fragmented and heavily regulated. By partnering...
NYSE:MET
NYSE:METInsurance

MetLife Board Additions And Debt Raise Spark Fresh Valuation Questions

MetLife (NYSE:MET) appoints Dan Glaser and Michelle Seitz to its Board of Directors. Both directors bring extensive global insurance and investment management experience to the company. MetLife also completes a US$1b fixed income offering to support its financial resources. MetLife, a global insurance and employee benefits provider, is adding two industry veterans to its Board at a time when scale, risk management, and capital flexibility matter to many insurers. Dan Glaser and Michelle...
NYSE:MNR
NYSE:MNROil and Gas

How Diverging Earnings and Revenue Trends Could Reframe Mach Natural Resources' Profit Story (MNR)

Mach Natural Resources LP recently reported that for the quarter ended December 2025, earnings fell year over year while revenues rose strongly, with analysts previously projecting a positive Earnings ESP of 35.92% despite the partnership holding a Zacks Rank of 5. This combination of weaker earnings, stronger revenue, and upgraded analyst estimates highlights how changing expectations around profitability and operational momentum can influence sentiment ahead of results. Now we will examine...
NasdaqGS:DASH
NasdaqGS:DASHHospitality

DoorDash Expands AI Ordering And Loyalty Tools To Deepen Platform Monetization

DoorDash (NasdaqGS:DASH) is rolling out AI powered pizza customization across its platform, giving customers more tailored menu options. The company is extending its Reservations feature to Chicago and additional US cities, widening access to bookable restaurant tables. DoorDash is integrating third party loyalty programs, including partners such as Weigel's, into its app experience. A new Franchise Opt In advertising tool is being introduced, allowing franchise owners to run brand aligned...
NYSE:DHR
NYSE:DHRLife Sciences

Does Danaher (DHR) Pairing a Higher Dividend With Investor Outreach Reveal Its Capital Allocation Priorities?

Danaher Corporation’s Board approved a regular quarterly cash dividend of US$0.40 per share, paid on April 24, 2026 to shareholders of record on March 27, 2026, and the company also presented at the TD Cowen 46th Annual Health Care Conference in Boston on March 3, 2026. This combination of a higher cash return to shareholders and direct engagement with healthcare investors highlights how Danaher is reinforcing interest around its biotechnology, life sciences, and diagnostics...
NasdaqGS:SIRI
NasdaqGS:SIRIMedia

Sirius XM’s Refinancing Could Be A Game Changer For Sirius XM Holdings (SIRI)

Sirius XM Holdings recently completed a cash tender offer, retiring nearly half of its 3.125% Senior Notes due 2026 and funding the transaction with new 2032 senior notes and cash on hand as part of a broader refinancing plan. By extending its debt maturity profile and actively managing near-term obligations, the company is reshaping its balance sheet in ways that matter for both bondholders and equity investors. We'll now examine how Sirius XM's decision to refinance and extend its debt...
NYSE:ASH
NYSE:ASHChemicals

Ashland (ASH) Valuation Check After Earnings Beat Sales Softness And Outlook Reaffirmation

Ashland (ASH) recently reported quarterly results that combined a loss from continuing operations with adjusted earnings ahead of estimates, while sales softened and the company reaffirmed its full-year sales and profit outlook. See our latest analysis for Ashland. The latest results and reaffirmed full year outlook came as the share price has weakened, with a 7 day share price return of 11.08% and a 30 day share price return of 14.12%. Over the longer term, total shareholder returns of 2.10%...
NYSE:LRN
NYSE:LRNConsumer Services

Stride Opens 2026–2027 Virtual School Enrollment As Valuation Signals Upside

Stride (NYSE:LRN) has opened enrollment for the 2026–2027 school year at its K12-powered tuition-free virtual public schools. The enrollment window covers multiple states, including Arizona, California, Colorado, Idaho, Michigan, Oregon, and Washington. This move broadens access to online K–12 education for families interested in full-time virtual public school options. For investors watching education technology, Stride sits at the intersection of public schooling and digital delivery,...
NYSE:BLCO
NYSE:BLCOMedical Equipment

Bausch Lomb LUMIFY Research Highlights Redness Trend And Potential Valuation Upside

Bausch + Lomb (NYSE:BLCO) has published new research in a leading ophthalmology journal on the rising global prevalence of ocular redness. The paper highlights clinical benefits and patient-focused advantages of its LUMIFY Redness Reliever eye drops. The study includes data on a new preservative free formulation aimed at consumers concerned about long term drop use. Bausch + Lomb, trading at $17.06, is putting fresh scientific backing behind one of its key over the counter eye care brands...